Indeed, recently a study reported a reduction in the non-classical CD14+CD16++ monocytes in AD patients compared with mild cognitive impairment patients or age-matched healthy controls (Saresella et al., 2014). The gene discussed is CD14; the disease is Alzheimer disease.